Squarepoint’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-172,875
| Closed | -$5.03M | – | 3145 |
|
|
2024
Q4 | $5.03M | Buy |
172,875
+11,006
| +7% | +$320K | 0.01% | 767 |
|
|
2024
Q3 | $7.43M | Buy |
161,869
+46,361
| +40% | +$2.13M | 0.01% | 583 |
|
|
2024
Q2 | $4.72M | Buy |
115,508
+51,743
| +81% | +$2.11M | 0.01% | 708 |
|
|
2024
Q1 | $1.63M | Buy |
63,765
+736
| +1% | +$18.8K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $570K | Sell |
63,029
-95,562
| -60% | -$865K | ﹤0.01% | 1617 |
|
|
2023
Q3 | $1.01M | Buy |
158,591
+110,206
| +228% | +$703K | ﹤0.01% | 1298 |
|
|
2023
Q2 | $537K | Buy |
48,385
+9,441
| +24% | +$105K | ﹤0.01% | 1562 |
|
|
2023
Q1 | $598K | Buy |
38,944
+6,860
| +21% | +$105K | ﹤0.01% | 1390 |
|
|
2022
Q4 | $712K | Buy |
+32,084
| New | +$712K | ﹤0.01% | 1281 |
|
|
2022
Q1 | – | Sell |
-11,273
| Closed | -$268K | – | 2723 |
|
|
2021
Q4 | $268K | Buy |
+11,273
| New | +$268K | ﹤0.01% | 1924 |
|
|
2021
Q3 | – | Sell |
-23,491
| Closed | -$580K | – | 2670 |
|
|
2021
Q2 | $580K | Buy |
23,491
+10,875
| +86% | +$269K | ﹤0.01% | 1512 |
|
|
2021
Q1 | $275K | Buy |
12,616
+2,843
| +29% | +$62K | ﹤0.01% | 1941 |
|
|
2020
Q4 | $249K | Buy |
+9,773
| New | +$249K | ﹤0.01% | 1998 |
|